Abstract:Background and objectives: Myasthenia gravis (MG) is a condition with significant phenotypic variability, posing a diagnostic challenge to many clinicians worldwide. Prolonged diagnosis can lead to reduced remission rates and morbidity. This study aimed to identify factors leading to a longer time to diagnosis in MG that could be addressed in future to optimize diagnosis time. Methods: One hundred and ten patients from 3 institutions in Melbourne, Australia, were included in this retrospective cohort study. Demographic and clinical data were collected for these patients over the first 5 years from diagnosis and at 10 years. Nonparametric statistical analysis was used to identify factors contributing to a longer diagnosis time. Results: The median time for MG diagnosis was 102 (345) days. 90% of patients were diagnosed before 1 year. Female patients took longer than male patients to be diagnosed (p = 0.013). The time taken for first presentation after symptom onset contributed most to diagnosis time (median 17 [141] days), with female patients and not working as contributory factors. Neurology referral took longer if patients had diplopia (p = 0.022), respiratory (p = 0.026) symptoms, or saw an ophthalmologist first (p < 0.001). Outpatient management compared with inpatient was associated with a longer time to be seen by a neurologist from referral (p < 0.001), for the first diagnostic result to return (p = 0.001), and for the result to be reviewed (p < 0.001). Ocular MG had a median greater time to neurologist review than generalized MG (median 5 [25] days vs 1 [13] days, p = 0.035). Electrophysiology tests took longer for outpatients than inpatients (median 21 [35] days vs 2 [8] days, p < 0.001). Outpatients were also started on treatment later than inpatients (p < 0.001). There was no association of MG severity, ethnicity, age, medical and ocular comorbidities, and public or private health service on diagnosis time. There was also no impact of time to diagnosis on Myasthenia Gravis Foundation of America outcomes, number of follow-ups or hospitalizations, or prevalence of treatments used. This study is limited by low patient numbers and its retrospective nature. Discussion: This study identified several factors that can contribute to a prolonged diagnosis time of MG. Patient and clinician education about MG and outpatient diagnostic efficiency needs emphasis. Further studies are also needed to explore the delayed presentation time of women and nonworking patients in MG.

Determinants of diagnostic delay in autoimmune atrophic gastritis

Comprehensive Clinicopathologic Features in Autoimmune Atrophic Gastritis: Insights from a European Cohort of 57 Patients

Mucosal Overexpression of Thymic Stromal Lymphopoietin and Proinflammatory Cytokines in Patients With Autoimmune Atrophic Gastritis

The impact of diagnosis delay on European patients with generalised myasthenia gravis

Autoimmune Atrophic Gastritis: A Clinical Review

Update on Serum Biomarkers in Autoimmune Atrophic Gastritis

Low Pepsinogen I/II Ratio and High Gastrin-17 Levels Typify Chronic Atrophic Autoimmune Gastritis Patients With Gastric Neuroendocrine Tumors

Distinguishing Features of Autoimmune Gastritis Depending on Previous Helicobacter pylori Infection or Positivity to Anti-Parietal Cell Antibodies: Results From the Autoimmune gastRitis Italian netwOrk Study grOup (ARIOSO)

Antral mucosa healing at long-term follow-up in patients with corpus atrophic gastritis and concomitant antral gastritis may mimic autoimmune gastritis

Clinicopathological characteristics of autoimmune gastritis: A single-center retrospective study

Proteomics signature of autoimmune atrophic gastritis: towards a link with gastric cancer

A Novel Endoscopic Artificial Intelligence System to Assist in the Diagnosis of Autoimmune Gastritis: a Multicenter Study

Antral mucosa healing at long-term follow-up in patients with corpus atrophic gastirits and concomitant antral gastritis may mimick autoimmune gastritis

Determinants of diagnostic delay in axial spondyloarthritis: an analysis based on linked claims and patient-reported survey data

Autoimmune gastritis: long-term natural history in naïve Helicobacter pylori-negative patients

Known Concepts from a New Perspective

Autoimmune gastritis: relationships with anemia and Helicobacter pylori status

Exploring Factors That Prolong the Diagnosis of Myasthenia Gravis

Diagnostic delay in patients from the international map of axial spondyloarthritis: geographic, socio-demographic and disease-related factors

Diagnostic delay in inflammatory bowel diseases in a German population